论文期刊

取消

高级检索

检索历史清除

首页> The Prostate> Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients.

Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients.

导出 LinkOut

翻译打印收藏纠错

作者： Masashi,Kato ^[1] ; Akihiro,Hirakawa ^[2] ; Yumiko,Kobayashi ^[3] ; Akiyuki,Yamamoto ^[4] ; Ryo,Ishida ^[5] ; Osamu,Kamihira ^[6] ; Tomoyasu,Sano ^[1] ; Tsuyoshi,Majima ^[1] ; Shohei,Ishida ^[1] ; Yasuhito,Funahashi ^[1] ; Naoto,Sassa ^[1] ; Takashi,Fujita ^[1] ; Yoshihisa,Matsukawa ^[1] ; Ryohei,Hattori ^[5] ; Momokazu,Gotoh ^[1] ; Toyonori,Tsuzuki ^[7]

作者单位： Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan. ^[1] Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. ^[2] Statistical Analysis Section, Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan. ^[3] Department of Urology, Toyohashi Municipal Hospital, Toyohashi, Japan. ^[4] Department of Urology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan. ^[5] Department of Urology, Komaki City Hospital, Komaki, Japan. ^[6] Department of Surgical Pathology, Aichi Medical University, Nagakute, Aichi, Japan. ^[7]

关键词 IDC-P androgen deprivation therapy neoadjuvant prostate cancer prostatectomy

主题词老年人(Aged);老年人, 80以上(Aged, 80 and over);雄激素拮抗药(Androgen Antagonists);癌, 导管内, 非浸润性(Carcinoma, Intraductal, Noninfiltrating);无病生存(Disease-Free Survival);人类(Humans);激肽释放酶类(Kallikreins);男(雄)性(Male);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);预后(Prognosis);前列腺特异抗原(Prostate-Specific Antigen);前列腺切除术(Prostatectomy);前列腺肿瘤(Prostatic Neoplasms);回顾性研究(Retrospective Studies)

DOI 10.1002/pros.23942

PMID 31860754

发布时间 2021-11-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Prostate

The Prostate

2020年80卷3期

284-290页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷